B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

被引:723
作者
Tseng, SY [1 ]
Otsuji, M [1 ]
Gorski, K [1 ]
Huang, X [1 ]
Slansky, JE [1 ]
Pai, SI [1 ]
Shalabi, A [1 ]
Shin, T [1 ]
Pardoll, DM [1 ]
Tsuchiya, H [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA
关键词
dendritic cells; T cell activation; B7; interferon gamma; costimulatory molecule;
D O I
10.1084/jem.193.7.839
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs), unique antigen-presenting cells (APCs) with potent T cell stimulatory capacity, direct the activation and differentiation of T cells by providing costimulatory signals. As such, they are critical regulators of both natural and vaccine-induced immune responses. A new B7 family member, B7-DC, whose expression is highly restricted to DCs, was identified among a library of genes differentially expressed between DCs and activated macrophages. B7-DC fails to bind the B7.1/2 receptors CD28 and cytotoxic T lymphocyte-associated antigen (CTLA)-4, but does bind PD-1, a receptor for B7-H1/PD-L1. B7-DC costimulates T cell proliferation more efficiently than B7.1 and induces a distinct pattern of lymphokine secretion. In particular, B7-DC strongly costimulates interferon gamma but not interleukin (IL)-4 or IL-10 production from isolated naive T cells, These properties of B7-DC may account for some of the unique activity of DCs, such as their ability to initiate potent T helper cell type 1 responses.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 41 条
  • [1] T-cell stimulation: an abundance of B7s
    Abbas, AK
    Sharpe, AH
    [J]. NATURE MEDICINE, 1999, 5 (12) : 1345 - 1346
  • [2] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [3] B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation
    Borriello, F
    Sethna, MP
    Boyd, SD
    Schweitzer, AN
    Tivol, EA
    Jacoby, D
    Strom, TB
    Simpson, EM
    Freeman, GJ
    Sharpe, AH
    [J]. IMMUNITY, 1997, 6 (03) : 303 - 313
  • [4] Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
    Dhodapkar, MV
    Steinman, RM
    Krasovsky, J
    Munz, C
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 233 - 238
  • [5] ICOS co-stimulatory receptor is essential for T-cell activation and function
    Dong, C
    Juedes, AE
    Temann, UA
    Shresta, S
    Allison, JP
    Ruddle, NH
    Flavell, RA
    [J]. NATURE, 2001, 409 (6816) : 97 - 101
  • [6] Dong HD, 1999, NAT MED, V5, P1365
  • [7] IDENTIFICATION OF RESIDUES IN THE V-DOMAIN OF CD80 (B7-1) IMPLICATED IN FUNCTIONAL INTERACTIONS WITH CD28 AND CTLA4
    FARGEAS, CA
    TRUNEH, A
    REDDY, M
    HURLE, M
    SWEET, R
    SEKALY, RP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) : 667 - 675
  • [8] FORTIER AH, 1994, ISOLATION MURINE MAC
  • [9] REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28
    FRASER, JD
    IRVING, BA
    CRABTREE, GR
    WEISS, A
    [J]. SCIENCE, 1991, 251 (4991) : 313 - 316
  • [10] Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
    Freeman, GJ
    Long, AJ
    Iwai, Y
    Bourque, K
    Chernova, T
    Nishimura, H
    Fitz, LJ
    Malenkovich, N
    Okazaki, T
    Byrne, MC
    Horton, HF
    Fouser, L
    Carter, L
    Ling, V
    Bowman, MR
    Carreno, BM
    Collins, M
    Wood, CR
    Honjo, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 1027 - 1034